Drug Trial Radar · NCT00000599
Cholesterol-Lowering Atherosclerosis Study (CLAS)
Last checked: Nov 20, 2026Latest source record: Dec 13, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
Not stated
Start
Jun 1980
Primary completion
Not stated
Study completion Nov 1994
Sponsor
- Lead sponsor
- National Heart, Lung, and Blood Institute (NHLBI)NIH
- Sponsor type
- NIH
- First posted
- Oct 28, 1999
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Primary purpose
- Treatment
- Who can join
- Male only, from 40 years, up to 59 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To determine whether combined therapy with the lipid lowering agents colestipol hydrochloride plus niacin would produce significant change in coronary, carotid, and femoral artery atherosclerosis and coronary bypass graft lesions as determined by angiography. Also, to determine possible correlations between lesion changes and plasma lipid and lipoprotein cholesterol levels and to explore interrelationships of atherosclerosis change in femoral, coronary, and carotid arteries.
Conditions
- Arterial Occlusive Diseases
- Cardiovascular Diseases
- Carotid Artery Diseases
- Cerebral Arteriosclerosis
- Cerebrovascular Disorders
- Coronary Arteriosclerosis
- Coronary Disease
- Heart Diseases
- Myocardial Ischemia
- Atherosclerosis
Interventions
colestipolDrug
niacinDrug
diet, fat-restrictedBehavioral
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.